Cost-effectiveness analysis of universal hypothyroidism screening in the general population aged 30–65 years in Spain
Key limitations include the use of constant transition probabilities and some inputs from international sources. Nonetheless, expert validation supports the model's relevance. The analysis adopts a conservative approach, excluding potential additional benefits like hyperthyroidism detection or integration with routine bloodwork, which could improve cost-effectiveness. Overall, hypothyroidism screening is a cost-effective strategy for the Spanish NHS, improving early detection, preventing progression, and enhancing quality of life in a frequently underdiagnosed population.
Authors
- Heidi De los Santos Real
- B Revilla
- Oswaldo Morales López
- Daniel Pérez-Troncoso (ORCID: https://orcid.org/0000-0003-0091-8148)
- Carles Zafón Llopis
- A Martos
- Olga Ojeda Rife
- Belén Citoler Berdala
- José Manuel Cucalón Arenal
Institutions
- Hebron University (PS)
- Outcomes Research Consortium (US)
- Merck KGaA, Darmstadt (Germany) (DE)
- Merck Serono S.A. (Switzerland) (CH)
- Primary HealthCare (MT)
- Vall d'Hebron Hospital Universitari (ES)
- Roots Community Health Center (US)
- Servicio Gallego de Salud (ES)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1080/13696998.2025.2563973
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00